ArticleOncology research2025

Lenalidomide regulates the CCL21/CCR7/ERK1/2 axis to inhibit migration and proliferation in diffuse large B-cell lymphoma.

Wen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.